ArticleThe Journal of clinical investigation2026
Corrigendum to Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.
Daqiang Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.